ZYBT
Zhengye Biotechnology Holding Limited
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.61
−1.23%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−9.4x
Market Cap
$47.86M
MomentumView details →
1D Return
−1.23%
YTD Return
+41.74%
RSI (14)
48.9
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−9.4x
Market Cap
$47.86M
RSI (14)
48.9
MomentumView details →
1D Return
−1.23%
YTD Return
+41.74%
SummaryUpdated Dec 1, 2025
Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) is a Chinese veterinary vaccine manufacturer that went public in January 2025. Founded in 2004 and headquartered in Jilin, China, the company has established itself as a specialized producer of vaccines for livestock and companion animals. Operating as a subsidiary of Securingium Holding Limited, Zhengye has built its business around serving China's large agricultural sector while also expanding into international markets including Vietnam, Pakistan, and Egypt.
Similar companies
Latest newsMore news →